| J3380 / eculizumab-aagh |
| 1 |
| Q5151 / (listed entries) |
| 1 |
| J9055 / cetuximab |
| 1 |
| J3111 / romosozumab-aqqg |
| 1 |
| J1305 / evinacumab |
| 1 |
| J1428 / eteplirsen |
| 1; 6 doses within 90 days (per linked entries) |
| J0180 / agalsidase beta (Fabrazyme) |
| 6 doses within 90 days; also listed with 4 doses within 60 days for related entries |
| J9395 / fulvestrant (Faslodex) |
| 4 doses within 60 days |
| J9394 / fulvestrant (505(b)(2)) |
| 4 doses within 60 days |
| J1561 / Gammaked, Gamunex-C (immune globulin) |
| 1 |
| J1557 / Gamunex-C, Gammaplex (immune globulin) |
| 1 |
| J0223 / Givlaari (givosiran) |
| 1 |
| J0257 / Glassia (alpha-1 proteinase inhibitor) |
| 1 |
| J9356 / Herceptin Hylecta (trastuzumab and hyaluronidase) |
| 2 doses within 60 days |
| J1559 / Hizentra (immune globulin) |
| 1 |
| J1575 / Hyqvia (immune globulin) |
| 1 |
| J0638 / Ilaris (canakinumab) |
| 1 |
| J3245 / Ilumya (tildrakizumab) |
| 1 |
| J9173 / Imfinzi (durvalumab) |
| 2 doses within 60 days |
| Q5103 / Inflectra (infliximab-dyyb) |
| 1 |
| J1576 / IVIG non-lyophilized (Panzyga) |
| 1 |
| J9272 / Jemperli (dostarlimab-gxly) |
| 2 doses within 60 days |
| J9354 / Kadcyla (ado-trastuzumab emtansine) |
| 2 doses within 60 days |
| J2840 / Kanuma (sebelipase alfa) |
| 6 doses within 90 days |
| J9271 / Keytruda (pembrolizumab) |
| 1 |
| J2507 / Krystexxa (pegloticase) |
| 1 |
| J1306 / Leqvio (inclisiran) |
| 1 |
| J3263 / Loqtorzi (toripalimab-tpzi) |
| 4 doses within 60 days |
| J0221 / Lumizyme (alglucosidase alfa) |
| 6 doses within 90 days |
| J3397 / Mepsevii (vestronidase alfa-vjbk) |
| 6 doses within 90 days |
| Q5107 / Mvasi (bevacizumab-awwb) |
| 2 doses within 60 days |
| J1458 / Naglazyme (galsulfase) |
| 6 doses within 90 days |
| J0219 / Nexviazyme (avalglucosidase alfa-ngpt) |
| 6 doses within 90 days |
| J2802 / Nplate (romiplostim) |
| 1 |
| J0485 / Nulojix (belatacept) |
| 1 |
| J2350 / Ocrevus (ocrelizumab) |
| 1 |
| J2351 / Ocrevus Zunovo (ocrelizumab and hyaluronidase) |
| 1 |
| J1568 / Octagam (immune globulin) |
| 1 |
| Q5114 / Ogivri (trastuzumab-dkst) |
| 1 |
| J0222 / Onpattro (patisiran) |
| 1 |
| Q5112 / Ontruzant (trastuzumab-dttb) |
| 2 doses within 60 days |
| J9299 / Opdivo (nivolumab) |
| 2 doses within 60 days |
| J9289 / Opdivo Qvantig (nivolumab & hyaluronidase) |
| 2 doses within 60 days |
| J9298 / Opdualag (nivolumab & relatlimab) |
| 2 doses within 60 days |
| J0129 / Orencia (abatacept) |
| 1 |
| J9316 / Phesgo (pertuzumab, trastuzumab, & hyaluronidase) |
| 2 doses within 60 days |
| J1459 / Privigen (immune globulin) |
| 1 |
| J1301 / Radicava (edaravone) |
| 1 |
| J0896 / Reblozyl (luspatercept-aamt) |
| 1 |
| J1745 / Remicade (infliximab) |
| 1 |
| Q5104 / Renflexis (infliximab-abda) |
| 1 |
| Q5123 / Riabni (rituximab-arrx) |
| 2 doses within 60 days |
| J9312 / Rituxan (rituximab) |
| 2 doses within 60 days |
| J9311 / Rituxan Hycela (rituximab and hyaluronidase) |
| 2 doses within 60 days |
| Q5119 / Ruxience (rituximab-pvvr) |
| 2 doses within 60 days |
| J9333 / Rystiggo (rozanolixizumab) |
| 2 doses within 60 days |
| J2353 / Sandostatin LAR Depot (octreotide) |
| 1 |
| J0491 / Saphnelo (anifrolumab-fnia) |
| (no value listed) |
| J1602 / Simponi Aria (golimumab) |
| 1 |
| J1299 / Soliris (eculizumab) |
| 1 |
| J1930 / Somatuline Depot (lanreotide) |
| 1 |
| J9022 / Tecentriq (atezolizumab) |
| 2 doses within 60 days |
| J9024 / Tecentriq Hybreza (atezolizumab & hyaluronidase) |
| 2 doses within 60 days |
| J3241 / Tepezza (teprotumumab) |
| 1 |
| Q5133 / Tofidence (tocilizumab-bavi) |
| 1 |
| Q5116 / Trazimera (trastuzumab-qyyp) |
| 2 doses within 60 days |
| J9317 / Trodelvy (sacituzumab govitecan) |
| 4 doses within 60 days |
| Q5115 / Truxima (rituximab-abbs) |
| 2 doses within 60 days |
| Q5135 / Tyenne (Tocilizumab-aazg) |
| 1 |
| Q5134 / Tyruko (Natalizumab-sztn) |
| 1 |
| J2323 / Tysabri (Natalizumab) |
| 1 |
| J1303 / Ultomiris (ravulizumab-cwvz) |
| 1 |
| J1823 / Uplizna (inebilizumab-cdon) |
| 1 |
| J9303 / Vectibix (panitumumab) |
| 4 doses within 60 days |
| J1427 / Viltepso (viltolarsen) |
| 1 |
| J1322 / Vimizim (elosulfase alfa) |
| 6 doses within 90 days |
| J3385 / VPRIV (velaglucerase alfa) |
| 6 doses within 90 days |
| J3032 / Vyepti (eptinezumab) |
| 1 |
| J1429 / Vyondys 53 (golodirsen) |
| 1 |
| J9332 / Vyvgart (efgartigimod) |
| 1 |
| J1558 / Xembify (immune globulin) |
| 1 |
| J9228 / Yervoy (ipilimumab) |
| 2 doses within 60 days |
| Q5118 / Zirabev (bevacizumab-bvzr) |
| 2 doses within 60 days |